SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2024: USD -18.15 M

SHL Telemedicine Ltd. EBITDA is USD -18.15 M for the year ending December 31, 2024, a -652.79% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2023 was USD 3.28 M, a 53.72% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2022 was USD 2.14 M, a -129.46% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2021 was USD -7.25 M, a -234.03% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2020 was USD 5.41 M, a -41.31% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)